Today on the CLL Society website, we share an interview with another doctor from Ohio State University, Dr. Jeff Jones, to discuss ibrutinib resistance, combination therapy and treating asymptomatic chronic lymphocytic leukemia (CLL).
We met at the CRC (CLL Research Consortium) Scientific Meeting in San Diego in April 2015. Please take a look here to see the interview.
Our inaugural newsletter was emailed out on Sept. 30th and the response was phenomenal. We owe profound thanks to our CLL Expert authors, John Byrd and Jennifer Brown, and our patient and caregiver authors, Linda Lannom, Ken Martin, Erin Michaela Sweeney, Mark Silverstein, Wayne Wells, and Kate Woronowicz. We are already putting together the next issue scheduled to be sent out by the end of the year. If you haven’t had a chance to peruse it, you can access it here.
If you have questions you like addressed in future newsletters, OR would be willing to answer 5 questions in our Reader Poll about the CLL Society website, OR would be interested in writing an article for future newsletters, please go to the Ask & Tell section. Our goal is to fulfill the unmet needs of the CLL community, so we always welcome your feedback and questions.
If you are receiving this email through a CLL Society Alert, you are all set. If you are receiving this through another method and haven’t already, please sign up here. Also, please forward this email to a fellow patient or caregiver who might benefit from knowing more about CLL.
Another reason to make sure all the folks that might be helped sign on is that we will be posting a backlog of great lectures and interviews and articles on CLL over the next few months leading up to ASH and this alert is your best friend in knowing what new material we have posted.
Save the date: We are planning a post-ASH patient education forum and CLL Society LA support group launch in conjunction with City of Hope on Dec. 12, 2015. More details to follow.
We are all this together
Volunteer Medical Director of the CLL Society